If you have vitiligo on your hands, fingers, feet or toes, you may find these areas slower and less predictable to repigment. This is known as acral vitiligo, and repeated friction, thicker skin and the location of the patches can make treatment more challenging.
One reason is that these areas have fewer hair follicles, which provide pigment-producing cells for repigmentation. Your palms and soles have no hair follicles, so you may need more realistic expectations about treatment compared with facial or trunk vitiligo. This does not mean your acral vitiligo cannot improve.
What Is Acral Vitiligo?
Acral vitiligo affects the more distant parts of your limbs, such as your hands, fingers, feet, ankles and toes. Your palms and soles can be particularly difficult to treat because they have no hair follicles, which can provide pigment-producing cells during repigmentation.
The underlying process is the same as other forms of vitiligo, but your hands and feet generally respond less well to treatment than areas such as the face or trunk. You may therefore see clear improvement elsewhere while your fingers or toes show only limited changes.
Why Are the Hands and Feet Harder to Repigment?
When you have vitiligo, you need pigment-producing cells to return to the affected skin for repigmentation. Your hair follicles provide an important source of these cells, which is why you may first notice tiny brown spots around individual hairs during treatment.
Your hands and feet have fewer hair follicles than many other areas, while your palms and soles have none. This means you may have fewer pigment-cell reservoirs available, so you can see better repigmentation elsewhere while these areas remain lighter.
Why Do Hair Follicles Matter So Much?
When you have vitiligo, you may notice tiny brown dots appearing around individual hairs as your skin begins to repigment. These dots can gradually enlarge and join together. Your hair follicles contain melanocyte stem cells that can help provide new pigment during treatments such as phototherapy.
You may have fewer follicles on your hands and even fewer towards your fingertips, while your palms and soles have none. This means you have fewer pigment-cell reservoirs available in these areas. Pigment can sometimes return through other pathways, but these are generally less predictable, so the exact location of your acral vitiligo can affect your treatment response.
Evidence Note
UK dermatology guidance recognises body site as an important factor in treatment response. The face and trunk generally repigment better than acral areas, so you may see very different results in different parts of your body even when you use the same treatment correctly.
This is why your dermatologist may assess each area separately rather than judging your treatment by one overall result.
Are the Fingertips and Toes Particularly Difficult to Treat?
Yes. If you have vitiligo on your fingertips or toes, you may find these areas among the hardest to repigment. Your fingers and toes have fewer hair follicles, while areas closer to the palms and soles have none, leaving fewer sources of pigment-producing cells.
You may therefore respond differently depending on where your patches are located. Your dermatologist can assess each area separately, as vitiligo on the back of your hand or upper foot may have more repigmentation potential than patches on your fingertips, toes or soles.
Does Thicker Skin Affect Treatment?
If you have vitiligo on your palms or soles, the thicker outer layer of your skin may make treatment more difficult. This can affect how easily topical medicines penetrate, while repeated pressure and friction may also contribute to poorer treatment response.
However, skin thickness is only one factor. You still need viable pigment-producing cells for repigmentation, so using more cream will not necessarily improve your results. You should use your prescribed treatment as directed, as applying too much may increase irritation or other side effects.
Does Friction Affect Acral Vitiligo?
Your hands and feet experience regular friction, pressure and minor injuries. In some people with vitiligo, repeated skin trauma may contribute to new patches through the Koebner response.
- Repeated rubbing: Tight footwear or frequent rubbing may irritate affected areas.
- Minor injuries: Cuts, abrasions or repeated trauma can sometimes trigger new patches.
- Pressure areas: Toes, heels and other high-pressure areas may be more exposed to repeated irritation.
- Everyday activity: You do not need to avoid normal activities, but reducing unnecessary friction may help protect your skin.
If you notice new patches developing repeatedly in areas of friction or injury, discuss this with your dermatologist. They can assess whether your vitiligo is active and advise you on suitable skin protection.
Does the Age of a Vitiligo Patch Affect Treatment?
If you have a newer vitiligo patch, you may have a better chance of repigmentation than with a long-standing patch. This can be especially important on your hands and feet, where you may already have a slower treatment response. You may also have better prospects if pigmented hairs remain within the affected area.
If the hairs in your patch have turned white, known as leukotrichia, your follicular pigment-cell reservoir may also be affected. This can be linked with a poorer response to treatment, although your dermatologist cannot predict your exact outcome from this feature alone.
Can Topical Steroid Treatment Work on the Hands and Feet?
Topical corticosteroids can help control the immune activity involved in vitiligo. However, if you have acral vitiligo, reducing inflammation does not always lead to strong repigmentation because fewer pigment-cell reservoirs are available in these areas.
Your dermatologist may recommend a limited course or intermittent treatment depending on your skin and the affected area. You should use steroids as prescribed, as prolonged or inappropriate use can cause skin thinning and other side effects. Treatment can also be considered successful if it helps control the progression of your vitiligo, even when full repigmentation is not achieved.
Can Tacrolimus or Other Topical Treatments Help Acral Vitiligo?
Tacrolimus and other topical calcineurin inhibitors can help control local immune activity without causing the skin thinning associated with prolonged steroid use. If you have acral vitiligo, your dermatologist may consider a topical calcineurin inhibitor in selected cases, although hands and feet generally respond less well than areas such as the face and neck.
Ruxolitinib cream is an NHS treatment option in England for eligible people aged 12 and over with non-segmental vitiligo involving the face when first-line topical treatments have not worked or are not suitable. If your vitiligo affects only your hands or feet without facial involvement, this specific NICE recommendation does not apply. Even in eligible patients, treatment response can vary by body site, and acral areas may remain more difficult to repigment.
Can Phototherapy Repigment Acral Vitiligo?
NB-UVB phototherapy can help treat vitiligo by reducing immune activity and supporting repigmentation. If you have acral vitiligo, however, you may see a weaker response because your hands and feet generally repigment less readily than the face or trunk.
You may still benefit from phototherapy, particularly if your vitiligo is active and treatment aims to control progression. Your response can also vary between areas, with patches near your wrists or ankles potentially behaving differently from those on your fingertips, toes, palms or soles. You should discuss the likely response and treatment duration with your dermatologist before starting a prolonged course.
Research Insight
A small split-body randomised study of 32 people found that both whole-body and targeted NB-UVB improved acral vitiligo disease activity over 24 weeks. However, measurable repigmentation of the hands and feet beyond the wrists and ankles was negligible.
Because the study was small and lasted only 24 weeks, it cannot predict how everyone will respond or whether longer treatment would produce more pigment. It does support setting realistic expectations: NB-UVB may help stabilise acral vitiligo even when visible colour return is limited.
Can Excimer Laser or Targeted UVB Help?
If you have a small number of vitiligo patches, targeted UVB or 308 nm excimer treatment can direct light specifically at the affected areas. Your dermatologist may consider this alongside a topical calcineurin inhibitor for localised vitiligo. However, targeted treatment may still produce limited repigmentation in acral areas because these sites have fewer melanocyte and follicular pigment-cell reservoirs.
You should not assume that increasing the light dose will produce better results on your fingertips or toes. Too much ultraviolet exposure can cause burns, so your treatment should be carefully dosed and reviewed. If excimer treatment is combined with a topical calcineurin inhibitor, your dermatologist should also explain the theoretical increased risk of skin cancer noted in UK guidance. They can then decide with you whether continuing treatment is worthwhile.
Are There Special Treatments for Resistant Hand and Foot Vitiligo?
If you have resistant acral vitiligo, your dermatologist may consider specialised combination treatments when standard options have not worked. The British Association of Dermatologists notes that COâ‚‚ laser combined with topical 5-fluorouracil may be considered for some adults with non-segmental vitiligo affecting the hands and feet, although this is not widely available.
You should not assume that a more invasive treatment will give better results. These approaches can have side effects and require careful selection, so your dermatologist can assess whether you are suitable and discuss the potential benefits and risks.
UK Guidance Note
British Association of Dermatologists guidance says COâ‚‚ laser combined with topical 5-fluorouracil may be considered in adults with non-segmental vitiligo affecting the hands and feet when other treatments have not worked.
This is a specialist option and is not widely available on the NHS.
Can Surgery Be Used for Acral Vitiligo?
If you have stable acral vitiligo that has not responded adequately to other treatments and it continues to cause you distress, your dermatologist may consider cellular grafting. UK dermatology guidance generally defines stable vitiligo as no new lesions and no progression of existing lesions during the previous 12 months. Surgical approaches may include techniques such as blister grafting or cell-suspension procedures, which aim to transfer pigment-producing cells from unaffected skin to the vitiligo patch.
You should also understand that surgery does not guarantee repigmentation on your hands or feet. Constant movement, friction and pressure can make these areas more difficult to treat and may affect healing or colour matching. Your specialist can assess whether surgery is appropriate for you and discuss realistic expectations.
Clinical Tip
If surgery is being considered, ask how the stability of your patch will be assessed. Serial photographs can help your dermatologist check whether a specific area has changed during the previous 12 months.
UK guidance notes that the stability of an individual lesion can be more useful than judging your vitiligo as a whole when considering a procedure such as cellular grafting.
What Can Affect How Well Your Acral Vitiligo Responds to Treatment?
Your dermatologist cannot predict your response with certainty, but several factors can provide useful clues. Your patch location, hair colour and how long you have had the vitiligo can all matter. You may have more potential for repigmentation if hairs within your patch remain pigmented, while white hairs can suggest a poorer response.
Your disease activity also matters. If you are developing new patches, treatment may initially focus on stabilising your vitiligo rather than rapid repigmentation. You should also remember that your individual response can differ from someone else’s, even when you receive similar treatment.
Factors That Can Affect Acral Vitiligo Treatment Response
| Factor | Likely effect on response |
| Patch on back of hand or upper foot | May respond better than fingertips, toes, palms or soles |
| Fingertips or toes affected | Often more resistant |
| Pigmented hairs remain | May suggest better repigmentation potential |
| White hairs within the patch | May indicate poorer follicular pigment reserve |
| Newer patch | May have better potential than a long-standing patch |
| Active, spreading vitiligo | Treatment may focus first on stabilisation |
| Stable vitiligo | May make selected surgical options more appropriate |
| Palms or soles | Particularly difficult because there are no hair follicles |
How Long Should You Continue Treatment Before Deciding It Has Not Worked?
If you have acral vitiligo, your response usually needs to be assessed over months rather than weeks. Topical treatments are commonly reviewed every three to six months, while NB-UVB may require a prolonged course depending on your treatment plan and response. Your dermatologist can use photographs and changes in the patch to decide whether treatment is helping.
You should not continue the same treatment indefinitely if there is no meaningful improvement. Your response may also differ between body areas, so you may see good results on your face or trunk while your fingertips remain resistant. Discuss your treatment goals with your dermatologist so you know what progress to look for.
What Can You Do If the Hands and Feet Do Not Repigment?
If your hands or feet do not repigment fully, you still have options. Your dermatologist can check whether your vitiligo is stable or active and review whether a different or combined treatment may be suitable. You can also use cosmetic camouflage or self-tanners to reduce the colour contrast if you wish.
You should continue protecting depigmented skin from sun exposure, as it can burn more easily and surrounding tanning may make patches more noticeable. A poor response on your fingers or toes does not mean you have failed treatment, as acral vitiligo can be naturally more resistant. When these areas are exposed, UK dermatology guidance recommends sunscreen with SPF 50 and a 4- or 5-star UVA rating on affected and surrounding skin.
Myth vs Fact
| Myth | Fact |
| Acral vitiligo cannot improve at all. | Improvement is possible, but hands and feet often respond less well than other areas. |
| More phototherapy always gives better results. | Higher exposure does not guarantee better repigmentation and can increase the risk of burns. |
| White hairs do not matter. | Leukotrichia can suggest reduced follicular pigment-cell reserves. |
| Surgery guarantees pigment return. | Acral areas can remain difficult even after surgical treatment. |
| Ruxolitinib works equally well everywhere. | Treatment response varies by body site, and hands and feet can be more resistant. |
Key Takeaways
- Acral vitiligo affects the hands, fingers, feet and toes.
- These areas often repigment less readily because they contain fewer hair follicles.
- Palms and soles have no hair follicles and can be particularly resistant.
- NB-UVB may help stabilise disease even when visible repigmentation is limited.
- White hairs within a patch can indicate a poorer response.
- Specialist treatments may be considered when standard options have failed.
- Surgery is generally reserved for carefully selected stable vitiligo.
Frequently Asked Questions
1. What is acral vitiligo?
Acral vitiligo affects the hands, fingers, feet, ankles and toes. The palms and soles can be particularly difficult to treat because they have no hair follicles. This can make repigmentation slower and less predictable.
2. Why is vitiligo on the hands and feet harder to treat?
Hands and feet generally have fewer hair follicles, which can provide pigment-producing cells during repigmentation. The palms and soles have no hair follicles at all. You may therefore see better results on your face or trunk than on your fingers or toes.
3. Are fingertips and toes particularly difficult to repigment?
Yes, fingertips and toes can be among the most resistant areas. They have fewer potential pigment-cell reservoirs than many other parts of the body. Your response can also vary depending on the exact location of each patch.
4. Does friction make acral vitiligo worse?
Frequent friction, pressure and minor injuries may affect vitiligo in some people. Repeated skin injury can sometimes trigger new patches through the Koebner response. You should reduce avoidable rubbing or pressure without stopping normal activities.
5. Can topical treatments help acral vitiligo?
Topical corticosteroids and calcineurin inhibitors such as tacrolimus may help control immune activity. However, repigmentation can still be limited because acral areas have fewer pigment-cell reservoirs. Your dermatologist can choose treatment based on your skin and how your vitiligo behaves.
6. Can phototherapy treat vitiligo on the hands and feet?
NB-UVB phototherapy can help some people with acral vitiligo, although the response may be weaker than on the face or trunk. Targeted UVB or 308 nm excimer treatment may also be considered for smaller patches. Treatment should be carefully dosed to avoid burns and other effects from excessive ultraviolet exposure.
7. Can surgery be used for resistant acral vitiligo?
Surgery may be considered when your vitiligo is stable, has not responded adequately to other treatments and continues to cause you distress. Procedures can transfer pigment-producing cells or tissue from unaffected skin to the affected area. However, hands and feet can be challenging because of movement, friction and pressure.
8. Does the age of a vitiligo patch affect treatment response?
Newer patches may have better potential for repigmentation than long-standing patches. You may also have a better response when the hairs within the affected area remain pigmented. White hairs, known as leukotrichia, can indicate a poorer treatment response.
9. How long should you continue treatment for acral vitiligo?
You may need several months of consistent treatment before your response can be properly assessed. Early signs can include small areas of pigment around hair follicles or at the edges of a patch. Your dermatologist can monitor your progress and decide whether continuing or changing treatment is appropriate.
10. What can you do if your hands and feet do not repigment?
If your acral vitiligo does not fully repigment, your dermatologist can review whether your condition is stable or active and consider other treatment options. Cosmetic camouflage or self-tanners can also help reduce colour contrast if you wish. You should continue protecting depigmented skin from sun exposure, as it can burn more easily.
Final Thoughts: Treating Vitiligo on the Hands and Feet
Acral vitiligo can be more difficult to repigment because the hands, fingers, feet and toes have fewer pigment-cell reservoirs. Your response can depend on factors such as the location, stability and duration of your vitiligo, so treatment expectations should be realistic.
If you are considering Vitiligo treatment in London, you can contact the London Dermatology Centre to discuss your options and arrange a consultation with one of our specialists.
References:
- Eleftheriadou, V. et al. (2022) ‘British Association of Dermatologists guidelines for the management of people with vitiligo 2021’, British Journal of Dermatology, 186(1), pp. 18–29. Available at: https://academic.oup.com/bjd/article/186/1/18/6593593
- Song, T. et al. (2026) ‘Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances’, Clinical, Cosmetic and Investigational Dermatology, 19, article 624165. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC13453360/
- Thind, A. et al. (2024) ‘Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial’, Photodermatology, Photoimmunology & Photomedicine, 40(2), article e12960. Available at: https://pubmed.ncbi.nlm.nih.gov/38480997/
- Grochocka, M. et al. (2023) ‘Management of Stable Vitiligo—A Review of the Surgical Approach’, Journal of Clinical Medicine, 12(5), article 1984. Available at: https://www.mdpi.com/2077-0383/12/5/1984
- National Institute for Health and Care Excellence (NICE) (2026) Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over. Technology appraisal guidance TA1140. Published 17 March 2026. Available at: https://www.nice.org.uk/guidance/ta1140